Clinical Trials Browser

INDUSTRY × Granulocyte-Macrophage Colony-Stimulating Factor × 1 year × Clear all

NCT04238819 2026-03-02

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

NCT03363373 2026-02-19

Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

Phase 2 Recruiting

122 enrolled 2 FDA

CNS

Neuroblastoma

NCT04229979 2025-10-01

REGAL

Phase 3 Active not recruiting

127 enrolled

Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute